Skip to main content
. 2020 Feb 5;53(3):e12777. doi: 10.1111/cpr.12777

Table 1.

Identified differentially expressed metabolites between HJC0152‐treated and control A549 cells

Metabolite Rt (s) m/z ESI± VIP FC P‐value
Adenosine monophosphate (AMP) 346.05 406.48 ± 1.66 0.36 .002
Adenosine 268.1 162.65 ± 3.87 0.29 .019
Adenine 134.05 155.07 ± 2.6 0.39 .033
Inosine 267.07 210.71 1.41 0.51 .01
Hypoxanthine 137.04 162.48 ± 3.28 0.4 .015
Adenosine 5'‐diphosphate (ADP) 426.02 439.47 2.35 0.4 .001
L‐glutamine 145.06 347.84 1.65 0.21 .002
L‐glutamate 148.06 372.63 ± 2.85 0.39 <.001
Deoxyguanosine triphosphate (dGTP) 505.99 463.13 2.07 0.51 .009
Uridine diphosphate glucose (UDP‐D‐glucose) 565.05 421.03 1.96 0.46 .001
Uridine 5'‐monophosphate (UMP) 323.03 417.94 1.47 0.34 <.001
Uridine 243.06 158.52 2.82 0.3 .004
Uracil 113.03 86.21 + 1.42 0.36 .013
Uridine 5'‐diphosphate (UDP) 402.99 452.34 ± 2.18 0.32 .001
Uridine 5'‐triphosphate (UTP) 482.96 472.04 1.24 0.48 .004
Glycerophosphocholine 258.11 363.48 + 8.08 2.38 .002
sn‐Glycerol 3‐phosphoethanolamine 215.06 143.17 + 3.47 0.02 .001
Choline 104.11 363.48 + 1.38 1.92 .004
Phosphorylcholine 184.07 455.46 ± 7.49 0.55 <.001
Glutathione disulphide 611.15 470.75 ± 5.09 0.24 <.001
Glutathione 308.09 377.21 ± 5.03 0.13 .009
L‐pyroglutamic acid 128.03 373.19 ± 2.31 0.33 <.001
Nicotinamide adenine dinucleotide (NAD) 662.1 412.11 ± 2.02 0.5 .001
Nicotinamide 123.05 65.3 + 1.93 0.63 .005
1‐Methylnicotinamide 137.07 278.4 + 3.1 0.37 .034
S‐methyl‐5'‐thioadenosine 296.08 48.84 ± 2.26 0.35 <.001
1‐Aminocyclopropanecarboxylic acid 84.04 372.78 + 1.75 0.41 <.001
N‐acetyl‐L‐aspartic acid 174.04 369.4 3.44 0.23 <.001
Succinate 117.02 363.98 1.41 0.36 <.001
Phosphocreatine 212.04 416.63 + 1.65 0.21 <.001
Taurine 124.01 275.4 ± 2.82 0.26 .001
Betaine 118.08 256.28 + 1.82 0.47 .011
Ketoisocaproic acid 129.05 41.54 6.87 3.57 .031
L‐valine 118.08 281.97 + 2.19 1.47 .03
cis‐9‐Palmitoleic acid 253.22 42.94 1.18 0.71 .01
Myristic acid 227.2 43.84 1.35 0.69 .014
Sphingomyelin (d18:1/18:0) 794.6 44.6 + 1.16 1.56 .048
Uridine 5'‐diphosphoglucuronic acid (UDP‐D‐glucuronate) 579.03 453.41 1.43 0.6 .002
Arachidonic acid (peroxide free) 303.23 41.45 7.3 3.13 .001
L‐malic acid 133.01 382.85 1.59 0.32 .007
Linoleic acid 279.23 42.1 4.03 1.61 .014
1‐Deoxy‐D‐xylulose 5‐phosphate 273.04 385.04 2.39 0.15 .024
Adenosine 3',5'‐diphosphate (PAP) 428.04 438.22 + 2.19 0.42 .001
1‐Oleoyl‐sn‐glycero‐3‐phosphocholine 522.36 138.27 + 5.52 0.26 <.001
N‐acetylglutamine 249.11 392.42 + 1.64 0.06 <.001
1‐Myristoyl‐sn‐glycero‐3‐phosphocholine 468.31 152.33 + 1.23 0.22 .001
1‐Palmitoyl‐sn‐glycero‐3‐phosphocholine 496.34 145.67 + 3.9 0.45 .001
Cyclic adenosine diphosphate ribose 540.05 412.11 1.37 0.51 .001
11(Z),14(Z)‐Eicosadienoic Acid 307.26 41.1 2.48 1.37 .001
7Z, 10Z, 13Z, 16Z, 19Z‐Docosapentaenoic acid 329.25 40.45 3.06 1.41 .002
Penicillin G 333.09 44.97 2.11 0.04 .003
1‐Stearoyl‐2‐hydroxy‐sn‐glycero‐3‐phosphocholine 524.37 135.57 + 1.96 0.43 <.001
1‐Stearoyl‐sn‐glycerol 3‐phosphocholine 568.34 131.65 + 1.75 0.13 <.001
1,2‐dioleoyl‐sn‐glycero‐3‐phosphatidylcholine 768.59 129.12 + 1.61 2.38 .014
1‐Palmitoyl‐2‐oleoyl‐phosphatidylglycerol 747.52 42.79 8.67 7.69 <.001
Ile‐Ala 203.14 41.63 + 1.5 0.27 .032
Myristoleic acid 225.18 43.57 1.35 0.43 <.001
Pentadecanoic acid 241.21 43.14 1.53 0.59 <.001
4‐Nonylphenol 219.17 32.12 2.2 3.03 <.001
Docosatrienoic acid 333.28 40.11 1.94 1.85 <.001
Adrenic acid 331.26 40.71 2.09 1.92 <.001
Cyclohexylamine 160.13 361.87 + 1.17 0.4 .001
DL‐lactate 89.02 222.39 3.46 0.5 .011

Abbreviations: FC, fold change; m/z, mass‐to‐charge ratio; Rt, retention time; VIP, variable importance in the projection.

HHS Vulnerability Disclosure